CY1105913T1 - Νεα τυποποιηση αepολυματος που πepιεχει ενα πολικο φθοριωμενο μοριο - Google Patents

Νεα τυποποιηση αepολυματος που πepιεχει ενα πολικο φθοριωμενο μοριο

Info

Publication number
CY1105913T1
CY1105913T1 CY20071100028T CY071100028T CY1105913T1 CY 1105913 T1 CY1105913 T1 CY 1105913T1 CY 20071100028 T CY20071100028 T CY 20071100028T CY 071100028 T CY071100028 T CY 071100028T CY 1105913 T1 CY1105913 T1 CY 1105913T1
Authority
CY
Cyprus
Prior art keywords
molecule
polar
fluorined
aeropollist
new specification
Prior art date
Application number
CY20071100028T
Other languages
English (en)
Inventor
Philippe Rogueda
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CY1105913T1 publication Critical patent/CY1105913T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία σταθερή φαρμακευτική τυποποίηση αερολύματος που προορίζεται για εισπνοή. Η τυποποίηση περιέχει μία ενεργή ουσία, ένα προωθητικό του αερολύματος, ένα πολικό φθοριωμένο μόριο κι ένα έκδοχο. Το προτιμώμενο προωθητικό είναι HFA 134a ή HFA 227 ή ένα μίγμα αυτών.
CY20071100028T 2000-07-11 2007-01-09 Νεα τυποποιηση αepολυματος που πepιεχει ενα πολικο φθοριωμενο μοριο CY1105913T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016876.5A GB0016876D0 (en) 2000-07-11 2000-07-11 Novel formulation
PCT/SE2001/001606 WO2002003958A1 (en) 2000-07-11 2001-07-10 Novel aerosol formulation containing a polar fluorinated molecule

Publications (1)

Publication Number Publication Date
CY1105913T1 true CY1105913T1 (el) 2011-04-06

Family

ID=9895336

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100028T CY1105913T1 (el) 2000-07-11 2007-01-09 Νεα τυποποιηση αepολυματος που πepιεχει ενα πολικο φθοριωμενο μοριο

Country Status (21)

Country Link
US (1) US20030194378A1 (el)
EP (1) EP1303258B1 (el)
JP (1) JP2004502719A (el)
KR (1) KR20030025265A (el)
CN (1) CN1455663A (el)
AT (1) ATE342048T1 (el)
AU (2) AU7286601A (el)
BR (1) BR0112322A (el)
CA (1) CA2415092A1 (el)
CY (1) CY1105913T1 (el)
DE (1) DE60123793T2 (el)
DK (1) DK1303258T3 (el)
ES (1) ES2273864T3 (el)
GB (1) GB0016876D0 (el)
IL (2) IL153726A0 (el)
MX (1) MXPA03000276A (el)
NO (1) NO20030133L (el)
NZ (1) NZ523379A (el)
PT (1) PT1303258E (el)
WO (1) WO2002003958A1 (el)
ZA (1) ZA200300075B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759042A (ja) * 1993-08-13 1995-03-03 Toshiba Corp 画像保管装置
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003047603A2 (en) * 2001-12-04 2003-06-12 Minnesota High-Tech Resources, Llc Breathable gas mixtures to change body temperature
CA2470520A1 (en) 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
MXPA04007294A (es) * 2002-02-01 2004-10-29 Astrazeneca Ab Composicion para inhalacion.
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
FR2851166A1 (fr) * 2003-02-13 2004-08-20 D Lab Utilisation d'un liquide volatil a pression atmospherique et a temperature ambiante pour la fabrication de compositions pharmaceutiques et/ou biologiques
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060188729A1 (en) * 2005-02-22 2006-08-24 Kai-Volker Schubert Washable leather with repellency
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US20090012250A1 (en) * 2007-07-03 2009-01-08 Yu-Chin Lai Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
KR100910848B1 (ko) * 2007-09-13 2009-08-06 재단법인서울대학교산학협력재단 알러지성 비염 치료약물을 유효성분으로 함유하는 비강분무용 마이크로스피어 및 이의 제조방법
US8586007B2 (en) 2007-10-19 2013-11-19 Wayne State University Co-polymer stabilizers for hydrofluoroalkane dispersions
EP2294044B1 (en) * 2008-04-28 2016-07-13 AL.CHI.MI.A. S.r.l. Fluoroalkyloxy alkanes, process for production and uses thereof
EP2459182B1 (en) * 2009-07-30 2017-09-06 University of Zürich Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
CN102574958B (zh) * 2009-10-09 2014-07-16 株式会社吴羽 新的1,1-二氟乙烯共聚物及其制造方法
EP2407150A1 (de) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Nano- und Mikropolymerpartikel zur Aufrechterhaltung einer niedrigen Oberflächenspannung in der Lunge und zum Schutz des pulmonalen Surfactants
JP6392753B2 (ja) * 2012-07-18 2018-09-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ フッ素化界面活性剤
KR101516057B1 (ko) * 2012-12-07 2015-04-30 가톨릭대학교 산학협력단 폐질환 치료용 흡입 제형 및 이의 제조방법
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
EP3946220A4 (en) * 2019-04-01 2023-04-05 Honeywell International Inc. PERSONAL CARE AEROSOL COMPOSITIONS, METHODS AND DEVICES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557294A (en) * 1967-10-12 1971-01-19 Allied Chem Fluorinated ethers as inhalation convulsants
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US5605882A (en) * 1992-05-28 1997-02-25 E. I. Du Pont De Nemours And Company Azeotrope(like) compositions of pentafluorodimethyl ether and difluoromethane
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
NZ306281A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5730894A (en) * 1996-04-16 1998-03-24 E. I. Du Pont De Nemours And Company 1,1,2,2,3,3,4,4-octafluorobutane azeotropic (like) compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
IL153726A (en) 2008-07-08
MXPA03000276A (es) 2003-06-06
BR0112322A (pt) 2003-07-08
NO20030133D0 (no) 2003-01-10
DK1303258T3 (da) 2007-01-22
CN1455663A (zh) 2003-11-12
KR20030025265A (ko) 2003-03-28
NZ523379A (en) 2004-06-25
NO20030133L (no) 2003-02-24
EP1303258A1 (en) 2003-04-23
JP2004502719A (ja) 2004-01-29
AU7286601A (en) 2002-01-21
IL153726A0 (en) 2003-07-06
DE60123793T2 (de) 2007-09-06
GB0016876D0 (en) 2000-08-30
AU2001272866B2 (en) 2005-08-11
ATE342048T1 (de) 2006-11-15
US20030194378A1 (en) 2003-10-16
CA2415092A1 (en) 2002-01-17
DE60123793D1 (de) 2006-11-23
PT1303258E (pt) 2007-01-31
WO2002003958A1 (en) 2002-01-17
ZA200300075B (en) 2004-04-05
EP1303258B1 (en) 2006-10-11
ES2273864T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
CY1105913T1 (el) Νεα τυποποιηση αepολυματος που πepιεχει ενα πολικο φθοριωμενο μοριο
CY1106549T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν κανναβη
ATE342053T1 (de) Formulierungen zur inhalation
ATE336268T1 (de) Medizinische aerosolzubereitung
CY1113318T1 (el) Ελευθερα απο ψευδαργυρο και φτωχα σε ψευδαργυρο σκευασματα ινσουλινης με βελτιωμενη σταθεροτητα
DK0553298T3 (da) Aerosolformulering omfattende beclomethason-17,21-dipropionat
EA199900991A1 (ru) Медицинские аэрозольные препараты
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
HUP0103925A2 (hu) Formoterolt tartalmazó, stabilan tárolható hatóanyag-koncentrátum
YU68199A (sh) Farmaceutske formulacije koje sadrže vorikonazol
PA8548701A1 (es) Azaindoles
PT1263725E (pt) Novos compostos
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
SE0103836D0 (sv) Novel compounds
GB0004128D0 (en) Novel compounds
CY1108133T1 (el) Σκευασμα αερολυματος για εισπνοη που περιεχει βρωμιουχο τιοτροπιο
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
DE60322200D1 (de) Formoterol und ciclesonid aerosol-formulierungen
DE60237831D1 (de) Azeotropähnliche zusammensetzungen aus tetrafluorethan, pentafluorpropan und wasser
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUP9902119A2 (hu) Difenil-stilbén származékok, mint Cox-2 inhibitorok és ezeket tartalmazó gyógyszerkészítmények
NO20006230D0 (no) Hyperforinderivater, anvendelsen derav og formuleringer inneholdende dem
HUP0301973A2 (hu) Opioid hatású vegyületet és (I) általános képletű vegyületet tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmények
BR0207476A (pt) Uso de um composto,e, composição farmacêutica